As of 2025-05-14, the Intrinsic Value of ADMA Biologics Inc (ADMA) is 22.34 USD. This ADMA valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 19.88 USD, the upside of ADMA Biologics Inc is 12.40%.
The range of the Intrinsic Value is 13.60 - 67.25 USD
Based on its market price of 19.88 USD and our intrinsic valuation, ADMA Biologics Inc (ADMA) is undervalued by 12.40%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 13.60 - 67.25 | 22.34 | 12.4% |
| DCF (Growth 10y) | 35.92 - 180.13 | 59.48 | 199.2% |
| DCF (EBITDA 5y) | 22.60 - 24.77 | 23.66 | 19.0% |
| DCF (EBITDA 10y) | 43.15 - 51.14 | 46.95 | 136.2% |
| Fair Value | 20.72 - 20.72 | 20.72 | 4.20% |
| P/E | 8.96 - 28.06 | 16.48 | -17.1% |
| EV/EBITDA | 8.38 - 19.88 | 12.65 | -36.4% |
| EPV | 1.04 - 1.32 | 1.18 | -94.1% |
| DDM - Stable | 12.08 - 76.36 | 44.22 | 122.4% |
| DDM - Multi | 18.40 - 90.98 | 30.67 | 54.3% |
| Market Cap (mil) | 4,742.57 |
| Beta | 1.21 |
| Outstanding shares (mil) | 238.56 |
| Enterprise Value (mil) | 4,711.76 |
| Market risk premium | 4.60% |
| Cost of Equity | 6.89% |
| Cost of Debt | 8.16% |
| WACC | 6.88% |